Century Therapeutics, Inc. (IPSC)
NASDAQ · Healthcare
Century Therapeutics, Inc. Total Liabilities 2022–2025
Century Therapeutics, Inc. annual/quarterly total liabilities history from 2022 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Century Therapeutics, Inc. total liabilities for the quarter ending December 31, 2025 were 64.8M, a 66.24% decrease year-over-year.
- Century Therapeutics, Inc. total liabilities for 2025 were 64.8M, a 66.24% decrease from 2024.
- Century Therapeutics, Inc. total liabilities for 2024 were 191.9M, a 9.04% increase from 2023.
- Century Therapeutics, Inc. total liabilities for 2023 were 175.9M, a 4.28% decrease from 2022.
- Century Therapeutics, Inc. total liabilities for 2022 were 183.8M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Century Therapeutics, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $65 |
| 2024 | $192 |
| 2023 | $176 |
| 2022 | $184 |
| Century Therapeutics, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $65 |
| 2024-12-31 | $192 |
| 2023-12-31 | $176 |
| 2022-12-31 | $184 |
Century Therapeutics, Inc. Total Liabilities — FAQ
Century Therapeutics, Inc. (IPSC) total liabilities over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IPSC's total liabilities history?
The chart and table above show Century Therapeutics, Inc.'s total liabilities by year and by quarter, including the growth rate.